SEC Form 4 · accession 0001237899-15-000033
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph L Goldstein
Director
Period of report
May 22, 2015
Accepted (ET)
May 26, 2015 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 22, 2015 | S | 2,000 | $513.74 | D | 22,000 | D | |
| Common Stock | May 22, 2015 | S | 2,000 | $514.81 | D | 20,000 | D |
Table II — derivative securities
No Table II lines on this filing.